Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Search trials by disease or condition

Enter a condition, keyword, or NCT ID

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

Results for “multiple sclerosis”

Video Games Therapy on Balance and Cognitive Functions in Mild to Moderate Impaired Multiple Sclerosis Patients.Completed
NCT03353974NAUpdated Nov 22, 2023
Sponsor: University Hospital of Ferrara
Multiple Sclerosis
Italy
Hematopoietic Stem Cell Transplantation for Treatment of Multiple Sclerosis in SwedenCompleted
NCT05029206N/AUpdated Nov 22, 2023
Sponsor: Uppsala University
Multiple Sclerosis · Multiple Sclerosis, Relapsing-Remitting
Sweden
A Community Wellness Program for Adults Living With Long-term Physical DisabilityCompleted
NCT03653390NAUpdated Nov 21, 2023
Sponsor: University of Washington
Physical Disability
United States
Protection Against Severe Coronavirus Disease 2019 in Patients With Multiple Sclerosis Stratified According to Disease Modifying TreatmentCompleted
NCT05834335N/AUpdated Nov 18, 2023
Sponsor: National MS Center Melsbroek
Multiple Sclerosis
Belgium
The Effects of FES in a Variety of Walking Conditions in People With MSUnknown
NCT03410498NAUpdated Nov 18, 2023
Sponsor: Queen Margaret University
Multiple Sclerosis
United Kingdom
Vibration Training for Preventing Falls in Healthy Population and Multiple SclerosisTerminated
NCT02694666NAUpdated Nov 18, 2023
Sponsor: Georgia State University
Falls Prevention
United States
Effect of Cooling on Balance Performance in Multiple SclerosisRecruiting
NCT06094855N/AUpdated Nov 15, 2023
Sponsor: Hunter College of City University of New York
Multiple Sclerosis
United States
A Study to Evaluate the Safety of Ozanimod Exposure During Pregnancy in Women With Multiple Sclerosis and Their InfantsActive Not Recruiting
NCT06133049N/AUpdated Nov 15, 2023
Sponsor: Bristol-Myers Squibb
Multiple Sclerosis
United States
Optimal Conditioning Regimen for Autologous Transplantation of Relapsing Remitting Multiple SclerosisWithdrawn
NCT05482542NAUpdated Nov 9, 2023
Sponsor: Scripps Health
Multiple Sclerosis, Relapsing-Remitting
United States
Phase II Clinical Trial of OCH-NCNP1Completed
NCT04211740Phase 2Updated Nov 9, 2023
Sponsor: National Center of Neurology and Psychiatry, Japan
Multiple Sclerosis, Relapsing-Remitting · Multiple Sclerosis, Secondary Progressive
Japan
Multiple Sclerosis Self Monitoring StudyUnknown
NCT06125301NAUpdated Nov 9, 2023
Sponsor: Amsterdam UMC, location VUmc
Multiple Sclerosis
Netherlands
Implementation of a Novel Functional Eye-Tracking Biomarker for Multiple SclerosisUnknown
NCT05277740N/AUpdated Nov 9, 2023
Sponsor: McGill University
Clinically Isolated Syndrome · Relapsing Remitting Multiple Sclerosis
Canada
Vaccine-generated Immunity in Ocrelizumab-treated Patients: Longitudinal Assessments (VIOLA)Completed
NCT04843774N/AUpdated Nov 8, 2023
Sponsor: NYU Langone Health
Multiple Sclerosis
United States
Improving Cognition in People With Progressive Multiple Sclerosis Using Aerobic Exercise and Cognitive RehabilitationCompleted
NCT03679468NAUpdated Nov 8, 2023
Sponsor: Sunnybrook Health Sciences Centre
Multiple Sclerosis, Primary Progressive · Cognitive Impairment
Canada
Role of Individualized Versus Traditional Exercise in Combating FatigueTerminated
NCT04796272NAUpdated Nov 2, 2023
Sponsor: Centre Hospitalier Universitaire de Saint Etienne
Multiple Sclerosis
France
Can Fatigability Neuromuscular Explain Chronic Fatigue in People With Multiple Sclerosis?Terminated
NCT03983720Phase 2Updated Nov 2, 2023
Sponsor: Centre Hospitalier Universitaire de Saint Etienne
Sclerosis, Multiple
France
The Effect of Extra Virgin Olive Oil in People With Multiple SclerosisUnknown
NCT04787497NAUpdated Nov 2, 2023
Sponsor: University of Cyprus
Multiple Sclerosis
Greece
Long-Term Outcomes and Durability of Effect Following Treatment With Cladribine Tablets for MS (CLASSIC-MS)Completed
NCT03961204Phase 4Updated Oct 31, 2023
Sponsor: EMD Serono Research & Development Institute, Inc.
Multiple Sclerosis (MS)
United States, Australia, Austria, Belgium, Bulgaria +24 more
Study of the Tolerability and Pharmacokinetics of Oral Doses of SAR442168 With a Food Effect Investigation in Healthy Adult ParticipantsCompleted
NCT06106074Phase 1Updated Oct 30, 2023
Sponsor: Sanofi
Multiple Sclerosis
United States
Aspirin for Exercise in Multiple Sclerosis (ASPIRE)Completed
NCT03824938Phase 3Updated Oct 27, 2023
Sponsor: Columbia University
Multiple Sclerosis
United States
The Effect Of Proprioceptive Neuromuscular Facilitation Techniqueson in Patients With Multiple SclerosisCompleted
NCT06102148NAUpdated Oct 26, 2023
Sponsor: Nilay Comuk Balci
Multiple Sclerosis
Turkey (Türkiye)
Investigation of Factors Affecting Functional Capasity in Multiple SclerosisUnknown
NCT06090084N/AUpdated Oct 23, 2023
Sponsor: Izmir Bakircay University
Multiple Sclerosis
Real World Analysis on Lymphocyte Reconstitution After Lymphopenia in Participants Treated by TecfideraCompleted
NCT04756687N/AUpdated Oct 23, 2023
Sponsor: Biogen
Multiple Sclerosis · Multiple Sclerosis, Relapsing-Remitting
France
Evaluation of Clinical, Morphologic and Biochemical Markers in Multiple SclerosisUnknown
NCT04892134N/AUpdated Oct 19, 2023
Sponsor: Medical University of Graz
Multiple Sclerosis
Austria
Non-invasive Spinal Cord Stimulation for Spasticity Control and Augmentation of Voluntary Motor Control in Individuals With Multiple SclerosisCompleted
NCT04486209EARLY_Phase 1Updated Oct 19, 2023
Sponsor: Medical University of Vienna
Multiple Sclerosis
Austria

Previous page Next page